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through physical interactions with Proliferating Cell Nuclear Antigen, PCNA. How this complex
exchange of PCNA binding partners is choreographed to ensure proper replication origin licensing,
DNA synthesis during normal replication or repair of DNA damage, chromatin assembly, DNA meth-
ylation, histone modiﬁcation, and sister chromatid cohesion is only beginning to be appreciated. In
this review, several roles of ubiquitin-related modiﬁcations in the recruitment and turnover of
PCNA-interacting proteins at the replication fork are considered.
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Replication of the genome and packaging of that duplicated DNA
into chromatin during S phase is achieved by a complex collection
of proteins that are dynamically present at the replication fork. Pro-
liferating Cell Nuclear Antigen, PCNA, plays a central role in coordi-
nating the association of these replication factors during DNA
replication as well as during recognition and repair of DNA damage.
The association of proteins with the replication fork through inter-
actions with PCNA is regulated by several mechanisms including:
(1) differences in afﬁnity of individual binding partners for PCNA
which can result in displacement of one PCNA interacting factor
by another, (2) the addition or removal of posttranslational modiﬁ-
cations to PCNA which either promotes or prevents protein-protein
interactions, (3) the unloading and replacement of PCNA by alterna-
tive clamp loading complexes, (4) ubiquitin-dependent proteolytic
digestion of PCNA followed by replacement of PCNA, and (5) ubiq-
uitination of interacting proteins bound to chromatin-associated
PCNA which promotes their degradation. The temporal exchange
of PCNA binding partners and the regulation of this process as well
as the composition of alternative PCNA complexes on the leading
and lagging strands of DNA are only partially appreciated. This re-
view explores several ways in which interactions between PCNAal Societies. Published by Elsevierand binding partners are choreographed and roles of ubiquitin re-
lated modiﬁcations in this dance.
PCNA interacts with numerous proteins to facilitate DNA repli-
cation and repair, epigenetic processes and sister chromatid cohe-
sion. At the replication fork, PCNA forms ring-shaped trimers
around DNA in which each monomer is arranged in a head to tail
orientation within the ring (Fig. 1). During DNA replication and
repair, PCNA is loaded onto DNA at the 30 ends of primer-template
junctions by the clamp-loading complex, RFC [1]. Once loaded onto
DNA, PCNA acts a sliding clamp that interacts with and enhances
the processivity of the DNA polymerases Pole and Pold on the lead-
ing and lagging strands of DNA [2–5]. Many PCNA binding proteins
interactwith a hydrophobic pocket and the interdomain connecting
loop on PCNA (Fig. 1A) through a conserved PCNA binding motif
known as a PIP (PCNA-interacting protein) box [6] (Fig. 1B). PIP
boxes fold into a hydrophobic domain that binds a hydrophobic
pocket beneath the interdomain connecting loop on PCNA [7,8].
Other residues outside of the PIP box may also affect the strength
of interactions with unmodiﬁed PCNA as well as with different
modiﬁed forms of PCNA (see below). In addition to Pold and Pole,
PCNA acts as a binding platform for several other proteins directly
involved in DNA synthesis ranging from the PIP box-containing Flap
endonuclease I, Fenl [9], and DNA ligase I [10,11] to several alterna-
tive polymerases and other proteins involved in DNA repair (see
below). PCNA also facilitates the establishment of sister chromatid
cohesion during S phase through recruiting the PIP box-containing
acetyltransferase Eco1 to chromatin [12]. Competition between PIPB.V. Open access under CC BY-NC-ND license.
Fig. 1. The interdomain connecting loop and a hydrophobic pocket on PCNA serve as a binding site for proteins containing PIP boxes. (A) Interdomain connecting loops
(yellow) within PCNA homotrimer (monomers are shown in green, red and blue) are highlighted in the PyMOL structure derived from [148]. (B) PCNA-interacting protein
(PIP) box consensus sequence. PIP boxes constitute a hydrophobic domain that binds within a hydrophobic pocket beneath the interdomain connecting loop on PCNA.
Additional residues outside of the PIP box on binding partners can also contribute to interactions with PCNA. CRL4Cdt2 substrates contain a positively charged residue at
position +4 adjacent to their PIP boxes.
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mation and stability, although the relative afﬁnity of most proteins
containing PIP boxes for PCNA remains to be determined.
2. PCNA, epigenetic processes and links to ubiquitin
In mammals, several PCNA binding factors inﬂuence chromatin
composition and epigenetic processes including the histone acetyl-
transferase p300 [13], the H4 K20 methyltransferase PR-SET7 that
co-localizes with PCNA at replication foci in vivo [14] (PCNA-
dependent ubiquitination of PR-Set7 is described below), the main-
tenance DNA methyltransferase Dnmt1 [15,16], and the histone
deacetylase HDAC1 [15,17,18]. PCNA is also bound by the chroma-
tin assembly factor CAF-1 [19,20], which, in mammals, targets
MBD1, a methyl CpG binding protein, and SETDB1, a H3 K9 meth-
yltransferase, to replication foci [6,21]. In budding yeast, silencing
defects associated with PCNA mutants have been linked to defects
in CAF-1 and ASF1-dependent chromatin assembly pathways
[22,23]. These PCNA mutants also have defects in interacting with
the acetyltransferases SAS-I plus Rtt109 and display global hypo-
acetylation of histone H4 K16, H3 K9 and H3 K56 [24,25]. Such his-
tone modiﬁcation defects result in mislocalization of silencing
proteins to off-target sites and inappropriate silent chromatin for-
mation as well as disruption of silent chromatin at normally
silenced loci. Analogous epigenetic defects may occur in mammals
when certain protein interactions with PCNA are disrupted.
In mammals, the transmission of histone modiﬁcation and DNA
methylation states during DNA replication has been proposed to be
facilitated by the Epigenetic Code Replication Machinery (ECREM)
[26]. A central component of ECREM, UHRF1 (Ubiquitin-like PHD
RING Finger1), is a multi-domain protein that exhibits ubiquitin li-
gase activity [27–29] and targets Dnmt1 to newly synthesized DNA
by preferentially binding hemimethylated DNA [30–33] as well as
di- and trimethylated forms of histone H3 K9 [28]. Both UHRF1 and
Dnmt1 bind the H3 K9-speciﬁc methyltransferase G9a, co-localize
with G9a in vivo and may also facilitate the transmission of these
modiﬁcations upon DNA replication [34,35]. Like PCNA, UHRF1 di-
rectly interacts with Dnmt1, is required for the maintenance of
DNA methylation patterns, and co-localizes with Dnmt1 and PCNAin vivo [32,36]. In addition, UHRF1 regulates Dnmt1’s activity dur-
ing the cell cycle via proteolytic degradation. Dnmt1’s stability is
modulated by reversible acetylation and ubiquitination events by
a large complex that includes PCNA, UHRF1, HDAC1, the acetyl-
transferase Tip60 and the ubiquitin protease USP7/HAUSP along
with Dnmt1 [37]. Signiﬁcantly, recent studies on human gliomas
indicate that disruption of interactions between UHRF1, Dnmt1
and PCNA contributes to oncogenesis by promoting global DNA
hypomethylation and correlates with poor survival rates [38]. Sev-
eral components of this larger complex may also form functional
subcomplexes. For example, PCNA, Dnmt1 and HDAC1 form a com-
plex in vitro and co-localize in vivo [15,17,18] (see also [39,40]).
However, how interactions between such alternative complexes
and PCNA are regulated during DNA replication to promote lo-
cus-speciﬁc chromatin modiﬁcation patterns governing epigenetic
processes is currently poorly deﬁned.
Multiple identical or different proteins can theoretically interact
with PCNA simultaneously through dynamic protein–protein
interactions at the replication fork, as three interconnecting loop
domains are present per PCNA trimer. Consistent with different
partners being capable of binding simultaneously to different sub-
units of PCNA, the Sulfolobu solfataricus homolog of PCNA, P2, is a
heterotrimer, with one subunit preferentially binding to DNA poly-
merase, a second to DNA ligase I and a third to Fen1. Together,
these interactions with PCNA would constitute the predicted archi-
tecture of replication complex on the lagging strand during the
synthesis and processing of Okazaki fragments [41]. Presumably,
ligation of Okazaki fragments could somehow signal the release
of the replication factors from the lagging strand and permit other
factors to bind PCNA, including CAF-1 for nucleosome assembly
and enzymes like Dnmt1 or HDAC1 for the propagation of epige-
netic states. Alternatively, a model in which chromatin-bound
PCNA exists in a back-to-back dimer of homotrimers [42] would
permit simultaneous association of both replication factors and
chromatin processing factors at the replication fork as well as pro-
vide a possible mechanism for targeting such factors to the leading
strand where PCNA is continually bound by Pole. However, this
model does account for how back-to-back homotrimers could be
assembled onto DNA as RFC exhibits orientation-speciﬁc loading
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Lupus Erythematosus, autoantibodies against PCNA are often pres-
ent. During disease progression, autoantibodies appear to be gen-
erated against entire multi-protein complexes containing PCNA
[43]. Investigation of such autoimmune responses to PCNA may
clarify the composition of complexes containing PCNA at the repli-
cation fork as well as how misregulation of protein–protein inter-
actions with PCNA contributes to abnormal epigenetic processes
during the initiation and progression of autoimmune diseases [44].
3. PCNA ubiquitination
The addition and removal of posttranslational modiﬁcations to
PCNA affect protein–protein interactions with PCNA during
responses to DNA damage. PCNA is differentially modiﬁed with
ubiquitin-related moieties in response to different forms of DNA
damage to promote DNA repair through several alternate repair
pathways. When the DNA replication machinery becomes stalled
upon encountering a lesion, activation of DNA damage responses
that permit the continuation of DNA replication through an ‘‘error
prone pathway’’ can occur. In this pathway, termed translesion
DNA synthesis, alternative low ﬁdelity DNA polymerases are uti-
lized to replicate the damaged DNA template. Alternatively, a
poorly deﬁned ‘‘error free’’ pathway, possibly involving template
switching, can be used in which homologous recombination repair
proteins utilize the newly synthesized sister chromatid to repair
the site of DNA damage. When the lesion reﬂects incomplete lag-
ging strand synthesis, an additional, recently discovered pathway
involving ubiquitination of PCNA becomes activated.
Ubiquitination of proteins occurs through three consecutive
steps. The 8.6 kDa protein ubiquitin is initially activated by an E1
ubiquitin-activating enzyme in an ATP-dependent manner. Acti-
vated ubiquitin is then transferred from the E1 enzyme to an E2
ubiquitin-conjugating enzyme via a thioester intermediate which
covalently links ubiquitin via a C terminal glycine residue to a ly-
sine residue on the substrate targeted by an E3 ubiquitin ligase
[45,46]. Monoubiquitination of the protein may alter protein–
protein interactions, and in the case of PCNA, occurs in response
to speciﬁc forms of DNA damage. Alternatively, this modiﬁcation
may then be converted to different forms of polyubiquitin chains,
depending on the type of linkages found between ubiquitin moie-
ties. When polyubiquitin chains are created through ligation via
e.g., K48 or K29 on the ubiquitin moieties, the protein will gener-
ally be marked for proteolysis via the 26S proteasome [47]. PCNA
can be targeted for degradation in this manner and misregulation
of turnover of PCNA leads to genome instability [48,49]. However,
what protein–protein interactions at the replication fork are regu-
lated by proteolysis of PCNA has yet to be explored in depth. K63
on ubiquitin is also used to form polyubiquitin chains on PCNA.
As described below, K63 polyubiquitin chains do not trigger prote-
olysis of PCNA, but rather act as signals signifying the presence of
speciﬁc forms of DNA damage.
3.1. PCNA K164 monoubiquitination promotes DNA repair by
translesion synthesis
In the error prone repair pathway, when the replication fork
stalls at the site of DNA damage, the major replicative polymerase,
Pold or Pole, is thought to be exchanged for a translesion synthesis
polymerase, e.g., Polf or Polg, which can then synthesize DNA
through the site of the lesion. Once beyond the site of damage, Pold
or Pole will once again resume the role of replicating DNA [50–52].
Whether translesion synthesis is relatively mutagenic is dependent
on the nature of the lesion and the alternative polymerase utilized
to replicate through that lesion ([53] and references within).Chromatin-associated PCNA is ubiquitinated at K164 in response
to damage in the template DNA strand caused by DNA alkylating
agents or UV irradiation [54] (Fig. 2). In budding yeast and mam-
mals, Rad6p/Rad18p orthologs catalyze monoubiquitination of
PCNA on K164 [54,55] and RNF8 is also important for monoubiqui-
tination of PCNAupon exposure to UV irradiation orMNNG inmam-
malian cells [56]. In addition, CLR4Cdt2 (see below) can directly
monoubiquitinate PCNA to promote translesion DNA synthesis
[57]. Both stalling of the replication fork and monoubiquitination
of PCNA are perquisites for the exchange of Pold and Polg [50]. Polg
speciﬁcally interacts with the monoubiquitinated form of PCNA
through an ubiquitin binding domain, UBD, plus a PIP box [58–60].
Once synthesis through the lesion has been completed, Polg may
be removed from the replication fork through a degradation mech-
anism involving CRL4Cdt2-dependent ubiquitination requiring chro-
matin-associated PCNA [61]. As monoubiquitinated PCNA is
refractory for replacing Polg with Pold, deubiquitination of K164
is also thought to promote the reassociation of Pold with PCNA at
the replication fork [50]. In mammals, deubiquitination of PCNA is
mediated by the deubiquitinase USP1 in conjunction with its inter-
acting partner UAF1 in the absence of DNA damage [62–64]. Mono-
ubiquitinated PCNA accumulates uponDNA damage; UV irradiation
leads to the downregulation of USP1 protein and transcripts, but
how monoubiquitinated PCNA is stabilized in response to other
damaging agents is not yet known [62–65].
3.2. PCNA K164 polyubiquitination promotes error free DNA repair
‘‘Error free’’ repair is triggered by polyubiquitination of PCNA
and results in the use of homologous recombination repair proteins
to repair DNA damage. This poorly deﬁned pathway appears to
promote DNA repair through the use of the newly synthesized sis-
ter chromatid as a template or for recombination [66–68]. During
error free repair, which may involve template switching (Fig. 2),
chromatin-associated PCNA is ﬁrst monoubiquitinated at K164 in
a Rad6/Rad18 dependent manner. This prerequisite modiﬁcation
is then targeted for polyubiquitination through K63 linkages by
the ubiquitin conjugating complex Ubc13-Mms2 and Rad5 in
Saccharomyces cerevisiae [54,69,70], the Rad8 ortholog in Schizosac-
charomyces pombe [71], and HLTF and SHPRH in human cells
[72–75]. Thus, poly- but not monoubiquitination of PCNA is lost
in ubc13, mms2 and rad5 mutants, whereas both mono- and poly-
ubiquitination is disrupted in rad6 and rad18 mutants. Rad5 also
exhibits DNA helicase activity and, on model substrates, can medi-
ate replication fork regression, consistent with a role in bypassing
lesions during DNA replication via template switching [76]. What
additional repair proteins speciﬁcally interact with polyubiquiti-
nated PCNA to promote error free repair is not known. USP1 also
negatively regulates polyubiquitination in mammals and therefore
may participate in deubiquitination of PCNA during recovery after
DNA repair by this pathway [77].
3.3. PCNA ubiquitination in response to replication stress on the
lagging strand
Recently, a previously unrecognized DNA damage response to
replication stress was uncovered in S. cerevisiae that results in
ubiquitination of K107 on PCNA in the presence of defective
Okazaki fragment processing in DNA ligase-deﬁcient cells [78]
(Fig. 2). Ubiquitination of PCNA upon depletion of DNA ligase I
has also been observed in human cells [78], although the modiﬁed
residue(s) on human PCNA has not yet been mapped. Mono- and
polyubiquitination of K107 on PCNA requires Mms2p, Ubc4p and
Rad5p. Monoubiquitination of PCNA is sufﬁcient to result in check-
point activation in DNA ligase-deﬁcient cells [78], but how this
Fig. 2. Ubiquitin-related modiﬁcations inﬂuence PCNAs function. Sumoylation of PCNA on K127 and K164 during DNA replication recruits Srs2 to PCNA and suppresses
homologous recombination. Mono- and polyubiquitination of PCNA on K107 is induced by a replication stress response to damage on the lagging strand during DNA
replication. Monoubiquitination of PCNA on K164 promotes switching to an alternate DNA polymerase (e.g., Polg) during DNA repair by translesion synthesis.
Polyubiquitination of PCNA on K164 supports error free DNA repair that may involve template switching. Whether each type of modiﬁcation can occur on more than one
PCNA monomer simultaneously and whether modiﬁcations signaling multiple pathways are present on PCNA simultaneously are unknown. Protein complexes mediating
each type of modiﬁcation are noted. See text for details. PCNA monomers (green, red and blue), modiﬁed residues on PCNA (yellow), sumoylation (S in blue circle),
ubiquitination (U in yellow circle). PyMOL structures are based on [148].
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PCNA has not yet been explored. Ubiquitination on K107 appears
to be critical for cellular recognition of damage to the nascent
DNA strand caused by a failure to ligate Okazaki fragments, as
cdc9-1 pol30 K107R mutants are inviable [78]. Polyubiquitin chains
in this pathway are created through K29 linkages [78], which are
often associated with targeting proteins for degradation by the
proteasome [47]. Thus, turnover of PCNA could be involved in
recovery from responses to this form of DNA damage.
4. PCNA sumoylation
Sumoylation of PCNA also inﬂuences protein–protein interac-
tions at the replication fork by creating or disrupting binding sites
for partners of PCNA. Sumoylation of PCNA occurs primarily in S
phase in a DNA damage-independent manner and may play a role
in regulating normal DNA replication [54,79]. Sumoylation of PCNA
is also involved in responses to DNA damage [53,54,66,80], andmay
play a negative regulatory function by preventing ubiquitination at
the same residues on PCNA. In S. cerevisiae, cell cycle-regulated
sumoylation of PCNA is the result of the combined action of the E2
Ubc9 and the E3 Siz1, which preferentially sumoylate chromatin-
bound PCNA [79], and the hydrolase Ulp1, which removes SUMO
from PCNA [55,81,82]. Ubc9/Siz1 sumoylates PCNA at K164 and, toa lesser extent, K127 or K127 plus K164 [54,79,83,84] (Fig. 2).
Ubc9/Siz1 also polysumoylates PCNA [54,55,80], although the sig-
niﬁcance of mono- versus polysumoylation is not known. Ubc9
can sumoylate K127 on PCNA in the absence of Siz1, although a sec-
ond E3, Siz2, may also play a minor role in sumoylation under these
conditions [79]. Sumoylation of PCNA is also conserved in verte-
brates [84]. Interestingly, human p150, the PIP box-containing large
subunit of CAF-1, binds SUMO2/3 in addition to PCNA andmediates
localization of SUMO2/3 to replication foci [85]. Whether SUMO2/3
is targeted to PCNAor another factor at the replication fork via CAF-1
during chromatin assembly on newly synthesized DNA remains to
be determined.
Binding of several proteins to PCNA is regulated by sumoyla-
tion. Sumoylation of PCNA promotes binding to the helicase Srs2p
and suppresses homologous recombination during S phase [86,87].
Interactions between an alternative clamp-loading complex and
PCNA at the replication fork also may be regulated by sumoylation.
Elg1, the large subunit of an alternative clamp loading complex,
binds both PCNA and the ubiquitin protease USP1-UAF1 [88,89],
and functions in sister chromatid cohesion [90,91] plus the
maintenance of genome stability [89,92,93]. Although Elg1 con-
tains a PIP box and interacts with unmodiﬁed PCNA, Elg1 also con-
tains three SUMO interacting domains, SIMs, and preferentially
co-precipitates with sumoylated PCNA [94]. Sumoylation of PCNA
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ners through interfering with access to the hydrophobic pocket on
PCNA. Consistent with this model, sumoylation of PCNA represses
binding of Eco1 in budding yeast and perturbs sister chromatid
cohesion [12]. Further biochemical characterization is required to
clarify how sumoylation impacts the composition of proteins
bound to PCNA at the replication fork However, sumoylation and
ubiquitination appear not to be required for PCNA to contribute
to the propagation of epigenetic states. Using PCNA mutants that
are mutated at K127 and K164, we have observed that the non-
ubiquitinated and non-sumoylated forms of PCNA can support
the establishment and maintenance of silent chromatin in budding
yeast (Fig. 3A), in contrast to other PCNA mutants with defects in
CAF-1 (e.g., Fig. 3B) and ASF1-dependent chromatin assembly path-
ways [22,23] (see above).
5. PCNA, CRL4cdt2-dependent ubiquitination
Ubiquitination of proteins during interactions with PCNA can
promote the turnover of protein complexes at the replication fork.
In addition to being ubiquitinated directly, PCNA is required for
CRL4Cdt2-dependent ubiquitination of several proteins whose
activities are tightly regulated during the cell cycle via proteolysis
[95]. CRL4cdt2 is a member of the Cullin-Ring E3 ubiquitin Ligase
family and consists of the scaffold protein Cul4A/B, an adaptor pro-
tein Ddb1 that bridges the complex’s substrate recognition factor
Cdt2 to Cul4, and a small Ring ﬁnger protein Rbx1/Roc1, which
recruits a different E2 ubiquitin-conjugating enzyme, UBCH8,
UBE2G1 or UBE2G2, to the complex, depending on the substrate
being targeted [96]. CRL4Cdt2 is unusual in that ubiquitination of
its substrates during S phase and in response to DNA damage re-
quires their association with chromatin-bound PCNA [95].
Although many proteins containing PIP boxes such as Fen1 are
stable [97], others are targets for ubiquitination by CRL4Cdt2 and
proteolytic degradation. Substrates of CRL4Cdt2 contain specialized
PIP boxes [97,98] that can exhibit an unusually high afﬁnity for
PCNA. In addition to the main eight amino acid motif, PIP boxes
present in CRL4Cdt2 substrates also contain a positively charged
residue at the +4 position that is important for recruiting CRL4Cdt2
to substrates while they are bound to PCNA [97] (Fig. 1B). Several
PCNA-dependent targets of CRL4Cdt2 targets include the replication
licensing factor Cdt1 [99–102], the CDK inhibitor Xic1 in Xenopus
[103], Spd1 in S. pombe [104], p21 [105–107], the histone methyl-
transferase PR-Set7 [108–110], CKI-1 [106], DNA polymerase gFig. 3. Ubiquitination and sumoylation of PCNA are not required for silencing. A. and
expressing POL30 or the indicated pol30 mutants [54,150]. Cells were plated onto rich me
to image acquisition. Independent experiments are shown in (A) and (B) and the variat
conditions for images and time of storage at 4 C. Dark pink colonies indicate HMR is sil
contains RD61,63AA and exhibits silencing defects in a CAF-1-dependent pathway as w[61], and E2F [111]. Biological impacts of interactions between
PCNA and two representative substrates, PR-Set7 and Cdt1, are
considered below.
5.1. PCNA-dependent ubiquitination of PR-Set7 regulates H4 K20
methylation
PCNA participates in cell cycle-dependent regulation of H4 K20
methylation, which is important for maintaining silent chromatin,
chromosome condensation and genome stability, through binding
the histone methyltransferase PR-Set7 (also referred to as Set7,
Set8 or Set9/KMT5A in S. pombe). PR-Set7 catalyzes monomethyla-
tion of H4 K20 [112–114]. H4 K20me1 levels are controlled
through both proteolysis of PR-Set7 [14,110,115,116] and further
modiﬁcations to this residue [117,118]. H4 K20me1 levels are very
low during S phase and rise in late S and G2 phases, peak during
mitosis, then fall again during G1 [116,117,119]. This reduction
in H4 K20me1 levels is primarily due to conversion to H4
K20me2 within one to two cell cycles and, for a small percentage
of H4, conversion to H4 K20me3 by the methyltransferases
Su(var)4-20h1 and Su(var)4-20h2 [117,118,120,121]. Thus, defects
in PR-Set7-dependent monomethylation of H4 K20 also result in
defects in di- and trimethylation of H4 K20. Although H4
K20me1 has been linked to transcriptional repression, H4
K20me1 also tends to be associated with transcriptionally active
regions and enriched in gene bodies, whereas H4 K20me3 is
enriched in some promoters, repetitive elements pericentric
heterochromatin, and in imprinting control regions [120,122–127].
PR-Set7 is subject to chromatin-bound PCNA-dependent ubiq-
uitination by CRL4Cdt2 plus UBCH8, which then targets PR-Set7
for proteosome-dependent degradation in G1 and S phase as well
as in response to DNA damage [96,108–110,128]. The E3 ubiquitin
ligase CRL1Skp2 also play a minor role in directing (PCNA-indepen-
dent) proteolysis of non-chromatin associated PR-Set7 during the
G1/S phase transition [108,110,115]. Chemical inactivation of the
proteasome permits visualization of co-localization of PR-Set7
and PCNA at replication foci and depletion of PR-Set7 leads to H4
K20 mono- and trimethylation defects, reduced rates of replication
fork progression, impaired S phase progression and double
stranded DNA breaks [129]. Expression of PR-Set7 mutants lacking
a PIP box results in stabilization of PR-Set7, a decrease in H4
K20me1, an increase in H4 K20me3 and the accumulation of cells
with <2C and >4C DNA content, consistent with chromosome
missegregation and/or re-replication events having occurredB. Colony color assays [149] monitoring silencing at HMR::ADE2 in S. cerevisiae
dia (YPD) and grown for 2 days at 30 C, then stored at 4 C for three or 4 days prior
ion in pigment accumulation between experiments reﬂect differences in exposure
enced and loss of silencing results in white, light pink or sectored colonies. pol30-8
ell as defects in H3 K9ac, H3 K56ac, and H4 K16ac [22–25].
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ﬁring and an increase in the distance between active replication
forks, implying that proper regulation of PR-Set7 expression via
PCNA and CRL4Cdt2 is critical for regulating origin licensing and/
or the timing of origin ﬁring [129]. As PR-Set7 associates with mi-
totic chromosomes, PR-Set7 is likely targeted to chromatin by
PCNA-independent mechanism(s) as well [110,116].
Misregulation of PCNA-dependent degradation of PR-Set7 also
contributes to genome instability through altered chromosome
condensation and DNA damage responses [109,130–132]. PCNA
plays a role in initiating responses to DNA damage through target-
ing PR-Set7 to sites of damage [110]. In turn, catalytically active
PR-Set7 is required for the recruitment of a mediator of DNA dam-
age checkpoint activation, 53BP1 (Crb2 in S. pombe), to damaged
DNA, likely via 53BP1 binding to methylated H4 K20 [110,133,
134]. Subsequent CRL4Cdt2-dependent degradation of PR-Set7
may then enable binding of other factors to PCNA during DNA
repair, but how this is coordinated with ubiquitination of PCNA
in response to DNA damage is unknown. Together, these ﬁndings
are consistent with PR-Set7 functioning during DNA replication
and repair in a manner in which rapid turnover of protein–protein
interactions with PCNA is important for function.5.2. PCNA-dependent ubiquitination of Cdt1 regulates licensing of
replication origins
A major mechanism for preventing re-replication in metazoans
involves cell cycle restriction of origin licensing andDNA replication
through the regulated protolysis of Cdt1 [100,101,106,135,136].
Both Cdt1 and the replication factor Cdc6 are required to recruit
the replicative helicase MCM2-7 to origins of replication during G1
and rapid degradation of Cdt1 restricts initiation of DNA replication
to once per S phase [137,138]. Ubiquitination of Cdt1 by CRL4Cdt2
targets Cdt1 for degradation, requires chromatin-bound PCNA and,
thus, is triggered during DNA replication or repair [99,100,135,
139–141]. Similarly, PCNA-dependent ubiquitination of the CDK
inhibitor p21 by CRL4Cdt2 also regulates origin ﬁring by promoting
nuclear export of Cdc6 [99,100,105–107,142]. Whether both Cdt1
and p21 can bind PCNA simultaneously for their ubiquitination
and subsequent degradation is unknown.
Like PR-Set7, CRL4Cdt2-dependent proteolysis of Cdt1 also oc-
curs in the presence of DNA damage [100,102,139,141,143–146].
Cdt1 may also play an important early role in responses to DNA
damage.
Shortly after UV irradiation of mammalian cells, Cdt1 tran-
siently accumulates at sites of DNA damage in its PIP box- and a
PCNA-dependent manner in conjunction with the arrival of PCNA
and Cdt2 [147]. Cdt2 similarly requires PCNA to accumulate tran-
siently at sites of DNA damage, whereas PCNA remains localized
to sites of DNA damage cells after degradation of Cdt1 [147]. Inter-
estingly, ubiquitination of PCNA in response to DNA damage can
inhibit proteolysis of Cdt1 under certain conditions [98]. These
observations imply DNA damage-induced ubiquitination or
sumoylation of PCNA prevents CRL4Cdt2-dependent degradation
by inhibiting binding of Cdt1 to PCNA. Other substrates of CRL4Cdt2
may be stabilized similarly upon modiﬁcation of PCNA in the pres-
ence of DNA damage. Further studies are needed to clarify the tem-
poral order of events governing PCNA-dependent protein–protein
interactions and posttranslational modiﬁcations to PCNA during
responses to DNA damage.6. Perspectives
High ﬁdelity genome duplication and efﬁcient propagation of
epigenetic states are governed by a collection of dynamic proteincomplexes containing PCNA at the replication fork. In recent
years, great strides have been made in identifying PCNA-inter-
acting factors and modiﬁcations to PCNA as well as several bio-
logical processes mediated by both. In the near future,
identiﬁcation of which proteins bind PCNA simultaneously to
form transient functional complexes in vivo will be critical for
the eventual understanding of how coordinated exchange of
these complexes at the replication fork contributes to the regu-
lation of DNA replication, DNA repair, epigenetic processes and
sister chromatid cohesion. Application of alternative strategies
for rapidly probing transient protein–protein interactions, includ-
ing single molecule-based approaches, have the potential to en-
able visualization of how these interactions with PCNA occur
dynamically. Moreover, an appreciation of how DNA damage-
dependent ubiquitination of PCNA inﬂuences interactions with
its numerous binding partners is needed to clarify why DNA
damage can inﬂuence a broad range of PCNA-dependent pro-
cesses, including epigenetic gene regulation and the ﬁdelity of
chromosome segregation.
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